Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00775866
What this trial is testing

MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy

Who this might be right for
Recurrent Prostate Cancer
University Health Network, Toronto 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06271551
What this trial is testing

Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy

Who this might be right for
Prostate Cancer
Central Finland Hospital District 310
Not applicableNot Yet RecruitingNCT07268469
What this trial is testing

Minimal Residual Disease in Solid Malignancies

Who this might be right for
Breast CancerNon Small Cell Lung CancerProstate Cancer+2 more
European Institute of Oncology 840
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Testing effectiveness (Phase 2)Ended earlyNCT03442556
What this trial is testing

Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

Who this might be right for
ATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+7 more
University of Washington 18
Early research (Phase 1)Study completedNCT02705469
What this trial is testing

ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Zenith Epigenetics 44
Not applicableStudy completedNCT01578902
What this trial is testing

Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 84
Testing effectiveness (Phase 2)Study completedNCT03735680
What this trial is testing

Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Who this might be right for
Breast CancerHead and Neck Squamous Cell CarcinomaColorectal Cancer+4 more
OncoNano Medicine, Inc. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06827080
What this trial is testing

Study on the Safety, Tolerability, and Preliminary Efficacy of 161Tb-NYM032 in Patients with Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, MCRPCCancer
Zhengguo Chen 15
Early research (Phase 1)WithdrawnNCT05567770
What this trial is testing

ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcer

Who this might be right for
Prostate Cancer Metastatic
Weill Medical College of Cornell University
Not applicableStudy completedNCT02237170
What this trial is testing

Immune Monitoring on Sipuleucel-T

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 36
Testing effectiveness (Phase 2)Looking for participantsNCT06772441
What this trial is testing

Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)

Who this might be right for
Prostate Cancer
German Oncology Center, Cyprus 30
Not applicableActive Not RecruitingNCT03630666
What this trial is testing

Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients

Who this might be right for
Prostate CancerOligometastasis
Institut Cancerologie de l'Ouest 256
Testing effectiveness (Phase 2)Study completedNCT01683994
What this trial is testing

Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 49
Not applicableStudy completedNCT00496249
What this trial is testing

The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 19
Testing effectiveness (Phase 2)Study completedNCT00117949
What this trial is testing

Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 82
Testing effectiveness (Phase 2)Ended earlyNCT05501548
What this trial is testing

Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Large-scale testing (Phase 3)Study completedNCT00003343
What this trial is testing

Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 525
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793435
What this trial is testing

A Phase 1/2 Trial of ADI-212 in mCRPC

Who this might be right for
Prostate Cancer Metastatic
Adicet Therapeutics 12
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Next Page